The Oxford Scientist

New way of producing fluorochemicals developed

Eleanor Garrigan Mattar reports on a groundbreaking method developed by Oxford researchers for synthesizing fluorochemicals.

Leah Fogarty discusses the complexities and urgent need for research on Capgras delusion, a poorly understood psychiatric condition.

Marianna Birkitt examines the multifaceted applications of microfluidics in biological research, ethical drug testing, and space exploration.

Isabelle Goodall-Summers explores the off-label use of Ozempic for weight loss, highlighting potential societal implications.

Lizzie Mushangwe examines how technology affects human senses, balancing potential benefits with ethical risks.

Ilke Boran explores the problem of scientific misattributions and representation in academia advocating for systemic solutions.

Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.

Lily Massey explores the potential of senolytics to combat age-related diseases, possibly improving the quality of human life in later years.

Eleanor Garrigan Mattar discusses the misconceptions about hydrogen as a green energy solution, highlighting its environmental impact.

Angelina Shcherbakowa delves into the enigma of Guam’s lytico-bodig disease, attempting to trace its potential origins.